grepcent / static financial knowledge base

Informational only - not investment advice.

SIC 2836 - Biological Products, (No Diagnostic Substances)

Division: Manufacturing. Major group: Chemicals And Allied Products. As of: 2026-02-24.

Companies

Macro Context

Sector financials

Peer figures are build-time aggregates of the SEC companyfacts financials already shown on member company pages. As of latest member filing date: 2026-02-24.

Companies With DataCompanies With RevenueAggregate RevenueMedian RevenueMedian Net MarginMedian Operating MarginMedian Revenue GrowthMedian Diluted EPS
5579,248,235,0009,890,600,00013.07%16.55%2.40%6.78

Peer Table

CompanyLatest RevenueRevenue FYNet MarginOperating MarginRevenue GrowthDiluted EPS
AMGN - AMGEN INC36,751,000,000202520.98%24.71%9.95%14.23
GILD - GILEAD SCIENCES, INC.29,443,000,000202528.90%34.04%2.40%6.78
BIIB - BIOGEN INC.9,890,600,000202513.07%2.22%8.79
MRNA - Moderna, Inc.1,944,000,0002025-145.16%-121.91%-39.93%-7.26
TECH - BIO-TECHNE Corp1,219,635,00020256.02%8.38%5.23%0.46

Sources

Macro Data

SEC Data